Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Amyris, Inc. (NASDAQ: AMRS).

Full DD Report for AMRS

You must become a subscriber to view this report.


Recent News from (NASDAQ: AMRS)

Amyris and ADL Bionatur Solutions Expand Production Agreement to Meet Growing Demand
EMERYVILLE, Calif. and LEÓN, Spain, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of pure, sustainable, fermentation-derived ingredients for Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announ...
Source: GlobeNewswire
Date: December, 10 2018 08:30
Amyris announces the sale of convertible notes
Amyris (NASDAQ: AMRS ) has entered into definitive agreements for the sale of $60M of unsecured convertible senior notes in a private placement. More news on: Amyris, Inc., Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: December, 07 2018 08:59
Amyris Takes Major Step Forward in Addressing its Convertible Debt
EMERYVILLE, Calif., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) (the “Company”), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it has...
Source: GlobeNewswire
Date: December, 07 2018 08:36
Amyris Partners with Camil Alimentos to Deliver Zero Calorie Sweetener Made from Sugarcane to Brazilian Consumers
Agreement between the Brazilian multinational and the American company provides exclusivity for Latin America and aims to meet the growing consumer demand for natural non-calorie sweetening options EMERYVILLE, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leade...
Source: GlobeNewswire
Date: December, 03 2018 07:00
Amyris Partners with Givaudan to Introduce a Tabletop Application for its Zero Calorie, Naturally Sourced Sweetener
EMERYVILLE, Calif., Nov. 30, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leader in the research, development and production of pure, sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, recently announced the launch of a new, s...
Source: GlobeNewswire
Date: November, 30 2018 08:57
Amyris Q3 Earnings Preview
Amyris ( AMRS ) is going to report Q3 earnings after the market closes on November 13. The company guides for $185-195M in annual revenue, but has only reported just under $50M in the first half of the year. This is normal for the company, as it ships specialty products in the second half of t...
Source: SeekingAlpha
Date: November, 07 2018 19:00
Twist Bioscience IPO - Love The Company, Hate The Price
Twist Bioscience ( TWST ) is going public this year. The company manufactures and sells DNA molecules with desired code, which is useful for just about anybody working with genetics. First off, I have a confession to make: I love the company. I see it at every synthetic biology event I go to, ...
Source: SeekingAlpha
Date: October, 30 2018 13:58
Amyris to Announce Third Quarter 2018 Financial Results on Tuesday, November 13, 2018
EMERYVILLE, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the third quarter ended September 30, 2018 after market close on Tuesday, November 13, 2018. The company will hold its quarterly conference call to discuss these results, as...
Source: GlobeNewswire
Date: October, 30 2018 08:30
Amyris Partners with IPCA Labs to Earn the 2018 CPhI Award for Excellence in Pharma: API Development
EMERYVILLE, Calif. and MADRID, Spain, Oct. 23, 2018 (GLOBE NEWSWIRE) -- At the prestigious CPhI Pharma Awards Gala held October 9, in Madrid, Ipca Laboratories, Ltd. was awarded the 2018 CPhI Pharma Award for “Excellence in Pharma: API Development” for its work with Amyris, In...
Source: GlobeNewswire
Date: October, 23 2018 08:30
Amyris Successfully Producing its New Zero Calorie Natural Sweetener at Industrial Scale
EMERYVILLE, Calif., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, is pleased to announce that industrial scale production o...
Source: GlobeNewswire
Date: October, 19 2018 08:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-124.364.3454.47734.26516,834
2018-12-114.444.364.55354.3015554,539
2018-12-104.334.4154.594.23758,019
2018-12-074.354.2954.674.272,155,762
2018-12-064.054.1954.223.951,378,408

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1248,053133,03636.1203Short
2018-12-1166,425132,00750.3193Short
2018-12-10103,466211,15848.9993Short
2018-12-07426,199792,88153.7532Short
2018-12-06167,644385,88043.4446Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on AMRS.


About Amyris, Inc. (NASDAQ: AMRS)

Logo for Amyris, Inc. (NASDAQ: AMRS)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: AMRS)

      Notification that form 10-Q will be submitted late
      Filing Type: NT 10-QFiling Source: edgar
      Filing Date: May, 16 2018
      Filing Type: CT ORDERFiling Source: edgar
      Filing Date: May, 14 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 14 2018
      Official notification to shareholders of matters to be brought to a vote (Proxy)
      Filing Type: DEF 14AFiling Source: edgar
      Filing Date: April, 27 2018
      Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act
      Filing Type: DFiling Source: edgar
      Filing Date: April, 27 2018
      Amendment to a previously filed 10-K
      Filing Type: 10-K/AFiling Source: edgar
      Filing Date: April, 24 2018
      Disclosure of dealings with Iran, such as contact with or support for Iran
      Filing Type: IRANNOTICEFiling Source: edgar
      Filing Date: April, 18 2018
      Securities offered to employees under employee benefit plans
      Filing Type: S-8Filing Source: edgar
      Filing Date: April, 18 2018
      Amendment to a previously filed 10-K
      Filing Type: 10-K/AFiling Source: edgar
      Filing Date: April, 18 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: April, 18 2018

       

       


      Daily Technical Chart for (NASDAQ: AMRS)

      Daily Technical Chart for (NASDAQ: AMRS)


      Stay tuned for daily updates and more on (NASDAQ: AMRS)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: AMRS)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AMRS is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of AMRS and does not buy, sell, or trade any shares of AMRS. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/